Antipsychotic medication and seizures: A review

被引:114
|
作者
Hedges, D [1 ]
Jeppson, K
Whitehead, P
机构
[1] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA
[2] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA
[3] Utah State Hosp, Provo, UT USA
关键词
D O I
10.1358/dot.2003.39.7.799445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Both first-generation and second-generation antipsychotic medications can lower the seizure threshold, increasing the chances of seizure induction. This article reviews the published literature concerning the seizure-lowering effects of first- and second-generation antipsychotic medication. Unfortunately, rigorously controlled studies are relatively infrequent, and case reports form a large part of the available literature, limiting the confidence with which firm conclusions can be drawn. Of the first-generation antipsychotic medications, chlorpromazine appears to be associated with the greatest risk of seizure provocation, although other first-generation anti-psychotics also lower seizure threshold. Conversely, molindone, haloperidol, fluphenazine, pimozide and trifluoperazine are associated with a lower risk of seizure induction. Clozapine is the second-generation antipsychotic most frequently associated with seizures, with risperidone appearing to confer a relatively low risk. Other factors such as history of seizure activity, concurrent use of other drugs that lower seizure threshold, rapid dose titration, slow drug metabolism, metabolic factors and drug-drug interactions appear to increase the chances of an antipsychotic medication inducing seizure activity. (C) 2003 Prous Science. All rights reserved.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 50 条
  • [1] Antipsychotic medication in schizophrenia: a review
    Lally, John
    MacCabe, James H.
    BRITISH MEDICAL BULLETIN, 2015, 114 (01) : 169 - 179
  • [2] Antipsychotic medication in childhood and adolescence:: a review
    López, MMG
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2001, 29 (01): : 41 - 46
  • [3] Brain Atrophy and Antipsychotic Medication - a Systematic Review
    Weinmann, S.
    Aderhold, V.
    Haegele, C.
    Heinz, A.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [4] Antipsychotic medication and oropharyngeal dysphagia: systematic review
    Miarons Font, Marta
    Rofes Salsench, Laia
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (12) : 1332 - 1339
  • [5] Hypothermia due to Antipsychotic Medication: A Systematic Review
    Zonnenberg, Cherryl
    Bueno-de-Mesquita, Jolien M.
    Ramlal, Dharmindredew
    Blom, Jan Dirk
    FRONTIERS IN PSYCHIATRY, 2017, 8
  • [6] Antipsychotic Medication and Oxidative Cell Stress: A Systematic Review
    Lepping, Peter
    Delieu, John
    Mellor, Richard
    Williams, John H. H.
    Hudson, Peter R.
    Hunter-Lavin, Claire
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (03) : 273 - 285
  • [7] Review of antipsychotic medication administration: A proposal of intermittent dosing
    Boshes, RA
    Manschreck, TC
    SCHIZOPHRENIA BULLETIN, 2002, 28 (02) : 203 - 222
  • [8] Medication management of antipsychotic treatment in schizophrenia-A narrative review
    Isohanni, Matti
    Jaaskelainen, Erika
    Miller, Brian J.
    Hulkko, Anja
    Tiihonen, Jari
    Moeller, Hans-Jurgen
    Hartikainen, Sirpa
    Huhtaniska, Sanna
    Lieslehto, Johannes
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (02)
  • [9] Depot antipsychotic medication in the treatment of patients with schizophrenia: A systematic review
    Fenton, MK
    Adams, CE
    Quraishi, S
    David, AS
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 188 - 188
  • [10] Systematic review of patient and nurse attitudes to depot antipsychotic medication
    Walburn, J
    Gray, R
    Gournay, K
    Quraishi, S
    David, AS
    BRITISH JOURNAL OF PSYCHIATRY, 2001, 179 : 300 - 307